Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
CASI Pharma Acquires HBV ANDA from Laurus Labs 11
CASI Pharma Acquires ANDA Portfolio from Sandoz 12
Licensing Agreements 13
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 13
Equity Offering 15
CASI Pharma to Raise USD48.5 Million in Private Placement of Shares 15
CASI Pharma to Raise USD50 Million in Private Placement of Shares 16
CASI Pharma to Raise up to USD25 Million in Public Offering of Shares 17
CASI Pharma to Raise USD23.8 Million in Private Placement of Units 18
CASI Pharma Raises USD3 Million in Private Placement of Shares 19
CASI Pharma Raises USD7.8 Million in Final Tranche of Private Placement of Shares 20
CASI Pharma Raises USD1 Million in Third Tranche of Private Placement of Shares 21
CASI Pharma Raises USD6 Million in Second Tranche of Private Placement of Shares 22
CASI Pharma Raises USD10.3 Million in First Tranche of Private Placement of Shares and Warrants 23
Entremed Completes Private Placement Of Units For US$11 Million 24
Debt Offering 25
EntreMed Completes Private Placement Of Convertible Notes Due 2012 For US$10 Million 25
CASI Pharmaceuticals Inc – Key Competitors 27
CASI Pharmaceuticals Inc – Key Employees 28
CASI Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 14, 2018: CASI Pharmaceuticals announces second quarter and first half 2018 financial and business results 30
May 15, 2018: CASI Pharmaceuticals Announces First Quarter 2018 Financial And Business Results 32
Mar 29, 2018: CASI Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results 34
Nov 14, 2017: CASI Pharmaceuticals Reports Third Quarter 2017 Financial Results 36
Aug 14, 2017: CASI Pharmaceuticals Reports Second Quarter 2017 Financial Results 37
May 15, 2017: CASI Pharmaceuticals Reports First Quarter 2017 Financial Results 38
Mar 31, 2017: CASI Pharmaceuticals Reports 2016 Fourth Quarter And Full Year Financial Results 39
Corporate Communications 40
Oct 02, 2018: CASI Pharmaceuticals appoints Larry Zhang as president to its China operations to lead commercialization 40
Jul 03, 2018: CASI Pharmaceuticals Added To Russell 2000, 3000 And Microcap Indexes 41
Product News 42
03/28/2017: CASI Pharmaceuticals Announces Poster Presentations At AACR Annual Meeting 42
Clinical Trials 43
Dec 01, 2017: CASI Pharmaceuticals Announces Poster Presentation At The 2017 San Antonio Breast Cancer Symposium (SABCS) On ENMD-2076 In Patients With Triple-Negative Breast Cancer (TNBC) 43
Sep 07, 2017: CASI Provides Update on its Cancer Drug Candidate, ENMD-2076 44
May 30, 2017: CASI Pharmaceuticals Announces Poster Presentation At ASCO On ENMD-2076 In Patients With Clear Cell Ovarian Carcinoma 45
May 18, 2017: CASI Pharmaceuticals Announces Abstract On ENMD-2076 In Clear Cell Ovarian Cancer 46
Apr 14, 2017: CASI Pharmaceuticals Reports On Enrollment Status Of ENMD-2076 Phase 2 Study In Triple-Negative Breast Cancer 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CASI Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CASI Pharma Acquires HBV ANDA from Laurus Labs 11
CASI Pharma Acquires ANDA Portfolio from Sandoz 12
Spectrum Pharma Enters into Licensing Agreement with CASI for Zevalin, Marqibo and Captisol-Enabled Melphalan 13
CASI Pharma to Raise USD48.5 Million in Private Placement of Shares 15
CASI Pharma to Raise USD50 Million in Private Placement of Shares 16
CASI Pharma to Raise up to USD25 Million in Public Offering of Shares 17
CASI Pharma to Raise USD23.8 Million in Private Placement of Units 18
CASI Pharma Raises USD3 Million in Private Placement of Shares 19
CASI Pharma Raises USD7.8 Million in Final Tranche of Private Placement of Shares 20
CASI Pharma Raises USD1 Million in Third Tranche of Private Placement of Shares 21
CASI Pharma Raises USD6 Million in Second Tranche of Private Placement of Shares 22
CASI Pharma Raises USD10.3 Million in First Tranche of Private Placement of Shares and Warrants 23
Entremed Completes Private Placement Of Units For US$11 Million 24
EntreMed Completes Private Placement Of Convertible Notes Due 2012 For US$10 Million 25
CASI Pharmaceuticals Inc, Key Competitors 27
CASI Pharmaceuticals Inc, Key Employees 28
CASI Pharmaceuticals Inc, Other Locations 29
CASI Pharmaceuticals Inc, Subsidiaries 29
List of Figures
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
CASI Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9